India to Netherlands: Apixaban Export Trade Route
India has recorded 257 verified shipments of Apixaban exported to Netherlands, representing a combined trade value of $11.9M USD. This corridor is served by 6 active Indian exporters, with an average shipment value of $46.2K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED, which accounts for 61% of total export value with 138 shipments worth $7.2M USD. On the buying side, MYLAN IRELAND LIMITED is the largest importer in Netherlands with $3.9M USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, SANDOZ PRIVATE LIMITED , INTAS PHARMACEUTICALS LIMITED — together control 92% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Netherlands Apixaban corridor is one of India's established pharmaceutical export routes, with 257 shipments documented worth a combined $11.9M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 61% of all export value, reflecting the consolidated nature of India's apixaban manufacturing sector.
Across 6 active suppliers, the average shipment value stands at $46.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with apixaban's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 31.4%, placing it at rank #5 among India's top apixaban export destinations globally.
On the import side, key buyers of Indian apixaban in Netherlands include MYLAN IRELAND LIMITED, Mylan Ireland Limited, Sandoz B.V. and 7 others. MYLAN IRELAND LIMITED is the single largest importer with 64 shipments valued at $3.9M USD.
